Xin, Yan
Xu, Fengyan
Gao, Yuying
Bhatt, Nivedita
Chamberlain, Jason
Sile, Saba
Hammel, Suzy
Holt, Robert J.
Ramanathan, Srini
Funding for this research was provided by:
Horizon Therapeutics
Article History
Accepted: 10 February 2021
First Online: 26 March 2021
Declarations
:
: Study NCT00400361 was funded by Hoffman La Roche; studies NCT01868997 and NCT03461211 and the conduct of these analyses were funded by Horizon Therapeutics plc.
: Yuying Gao and Fengyan Xu received consulting fees from Horizon Therapeutics; Yan Xin, Nivedita Bhatt, Jason Chamberlain, Saba Sile, Suzy Hammel, Robert J. Holt, Thompson, and Srini Ramanathan are employed by and own stocks in Horizon Therapeutics.
: The trials were approved by institutional review boards of participating institutions and performed in accordance with the Declaration of Helsinki.
: Patients provided written informed consent.
: Not applicable.
: Data will not be provided.
: Not applicable.
: Not applicable.